drugset / Trial / NCT04489511
Study of STG-001 in Subjects With Stargardt Disease
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is an open-label, multicenter study in subjects with Stargardt disease, comparing 2 doses of STG-001 with regard to safety, pharmacokinetics and pharmacodynamics.
Timeline
- Start
- 2020-10-01
- Primary completion
- 2021-04-24
- Completion
- 2021-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STG-001 | Small molecule | — | Oral |